BRD4

Jiaxiang Xie1,2,3, Jingqi Zhang1,2,3, Gan Xiong1,2,3

  • 1Hospital of Stomatology, Sun Yat-sen University, Guangzhou, China.

Oral diseases
|October 6, 2023
PubMed
概括

odomain-4 (BRD4) 在乳腺母细胞瘤 (AM) 中被上调,导致瘤的进展和复发. 用BET抑制剂抑制BRD4为AM管理提供了一个有前途的治疗策略.